ijms-logo

Journal Browser

Journal Browser

CoA in Health and Disease 3.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 1264

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology of Polish Academy of Sciences, 02-093 Warsaw, Poland
Interests: physiology; endocrinology; metabolism; lipids; lipogenesis; lipolysis; stearoyl-CoA desaturase; angiogenesis; cardiovascular system; mitochondria; obesity; type 2 diabetes; transcription factors
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

CoA and its thioester derivatives are crucial components of numerous biosynthetic and degradative pathways of cellular metabolism (including the synthesis and oxidation of fatty acids, the Krebs cycle, ketogenesis, the biosynthesis of cholesterol and acetylcholine, and the degradation of amino acids), post-translational modifications of proteins, and the regulation of gene expression. Consequently, it is not surprising that the abnormal biosynthesis of CoA/CoA derivatives is associated with numerous pathologies, including diabetes, neurodegeneration, Reye’s syndrome, vitamin B12 deficiency, cardiac hypertrophy, and cancer. This Special Issue of the IJMS will showcase selected novel research articles covering the multiple roles of CoA and its derivatives in extracellular and intracellular signaling functions in physiology and pathology.

Topics of interest to this Special Issue include, but are not limited to, the following:

  • CoA synthesis and degradation;
  • CoA transport and mitochondria;
  • Extracellular functions of CoA/CoA thioesters;
  • CoA/CoA thioesters as intracellular signaling molecules;
  • Physiological and pathological changes in cellular CoA concentrations;
  • Interconversion between CoA and its thioester derivatives in health and disease;
  • The roles of nutrients, hormones, and other factors in the regulation of CoA levels in cells;
  • Acyl-CoA metabolism;
  • Association of CoA/acyl-CoA with fatty acid metabolism.

In addition, critical reviews of the status and perspectives regarding the role of CoA in pathophysiology are welcomed.

Dr. Pawel Dobrzyn
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • energy production
  • impaired metabolism
  • Acyl-CoA synthesis and function
  • Acetyl-CoA
  • CoA analogues
  • oxidative stress
  • hereditary diseases

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 4232 KiB  
Review
Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer’s Disease
by Xue-Ying He, Jannusz Frackowiak, Carl Dobkin, William Ted Brown and Song-Yu Yang
Int. J. Mol. Sci. 2023, 24(24), 17604; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms242417604 - 18 Dec 2023
Viewed by 999
Abstract
Type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10) is the HSD17B10 gene product playing an appreciable role in cognitive functions. It is the main hub of exercise-upregulated mitochondrial proteins and is involved in a variety of metabolic pathways including neurosteroid metabolism to regulate allopregnanolone homeostasis. Deacetylation [...] Read more.
Type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10) is the HSD17B10 gene product playing an appreciable role in cognitive functions. It is the main hub of exercise-upregulated mitochondrial proteins and is involved in a variety of metabolic pathways including neurosteroid metabolism to regulate allopregnanolone homeostasis. Deacetylation of 17β-HSD10 by sirtuins helps regulate its catalytic activities. 17β-HSD10 may also play a critical role in the control of mitochondrial structure, morphology and dynamics by acting as a member of the Parkin/PINK1 pathway, and by binding to cyclophilin D to open mitochondrial permeability pore. 17β-HSD10 also serves as a component of RNase P necessary for mitochondrial tRNA maturation. This dehydrogenase can bind with the Aβ peptide thereby enhancing neurotoxicity to brain cells. Even in the absence of Aβ, its quantitative and qualitative variations can result in neurodegeneration. Since elevated levels of 17β-HSD10 were found in brain cells of Alzheimer’s disease (AD) patients and mouse AD models, it is considered to be a key factor in AD pathogenesis. Since data underlying Aβ-binding-alcohol dehydrogenase (ABAD) were not secured from reported experiments, ABAD appears to be a fabricated alternative term for the HSD17B10 gene product. Results of this study would encourage researchers to solve the question why elevated levels of 17β-HSD10 are present in brains of AD patients and mouse AD models. Searching specific inhibitors of 17β-HSD10 may find candidates to reduce senile neurodegeneration and open new approaches for the treatment of AD. Full article
(This article belongs to the Special Issue CoA in Health and Disease 3.0)
Show Figures

Figure 1

Back to TopTop